ARCHIVES

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

NCI awards $7.3 Million for Studies In Cancer communications

October 15, 1993

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014

In Brief: Center wins $10 Million To coordinate Study; Albert Einstein Center Name Comprehensive

December 5, 1997

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004